Talion

Talion is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. Talion was approved in Japan for use in the treatment of allergic rhinitis and uriticaria/puritus in July 2000 and January 2002, respectively, and is marketed by Tanabe Seiyaku Co., Ltd. under the brand name Talion®. It is currently undergoing trials in the U.S.

Talion - Pharmacology:

Talion has three primary mechanisms of action. It is a non-sedating, selective antagonist of the histamine 1 (H1) receptor, it has a stabilizing effect on mast cells, and it suppresses the migration of eosinophils into inflamed tissues.

Generic name, Overdose, Half Life Talion, Food Interactions, Chemical, etc..

Talion see also


Chemical structure:
O N N Cl O O H H H H H H H H H H H H H H H H H H H H H H H H H C21H25ClN2O3 2D chemical structure C21H25ClN2O3 SVG | 2D structure Cetirizine | Bepotastine | C21H25ClN2O3 chemical names, chemical properties, classification C21H25ClN2O3